Cesarean Section; Dehiscence

2

Review clinical trials related to Cesarean Section; Dehiscence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect

GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect(CSD) patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.

Participants needed: 94
Trial details
Age: 18-50Biological sex: FemaleType: InterventionalSponsor: Xinhua Hospital, Shanghai Jiao Tong University School of MedicineUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Clearly diagnosed with CSD complicated with adenomyosis [+6]

Indefinite diagnosis. [+6]

Status: Recruiting

Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial

The objective of this randomized monocentric study is to assess potential variations in the incidence and severity of isthmocele morbidity among women undergoing cesarean section with either single or double-layer closure of the hysterotomy. Our primary outcome aims to investigate whether there is a reduction in the median duration of intermenstrual spotting in patients belonging to the two respective closure groups

Participants needed: 150
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoUpdated: Mar 13, 2024Locations: 1
Eligibility criteria

nulliparous [+6]

coagulopathy [+8]